WAMBEKE DAVID J. (Chief Business Officer) purchased 20.0% of their position (33.33K shares) of NEUROONE MEDICAL TECHNOLOGIES CORP on the open market
Open‑market purchase worth $67.0K — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/8/2026ACC: 0001971798-26-000005
Officer· Chief Business Officer
Since Mar 2026
+68.33K
Net shares
Net buyer
$67.0K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
68.33K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+33.33K
Price / share
$2.01
Trade value
$67K
% of position
20.0%
8/27/2026
166.67K→200K
Total
Net shares
+33.33K
Net value
$67K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/27/2026 | P · Purchase | +33.33K | $2.01 | $67K | 20.0% | 166.67K | 200K |
| Total | +33.33K | $67K | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
35K shares
Shares
+35K
Strike price
1.77
Held after
35K
Exercisable
—
8/28/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock35K shares | 8/28/2026 | A · Award | +35K | 1.77 | — | 35K |